Senolytics: charting a new course or enhancing existing anti-tumor therapies?
Crossref DOI link: https://doi.org/10.1007/s13402-024-01018-5
Published Online: 2024-12-04
Published Print: 2025-04
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Czajkowski, Konrad
Herbet, Mariola
Murias, Marek
PiÄ…tkowska-Chmiel, Iwona
Text and Data Mining valid from 2024-12-04
Version of Record valid from 2024-12-04
Article History
Accepted: 21 November 2024
First Online: 4 December 2024
Declarations
:
: The authors declare no competing interests.